13F
中

IDXX IDEXX LABORATORIES INC

2026Q1 · CUSIP 45168D104 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
1,294
Δ holders QoQ
-75
Breadth percentile
Top 99%
Whale holders
326
Δ whales
+2
Inst. holding value
$39.5B
New positions
124
Closed positions
199
Price momentum (1Q)
-12.8%
Put / Call
14/11

Breadth history (34 quarters)

2018Q1: Δ+32 · h=626 2018Q2: Δ+12 · h=638 2018Q3: Δ+34 · h=672 2018Q4: Δ-22 · h=650 2019Q1: Δ+13 · h=663 2019Q2: Δ+31 · h=694 2019Q3: Δ+7 · h=701 2019Q4: Δ+37 · h=738 2020Q1: Δ-6 · h=732 2020Q2: Δ+48 · h=780 2020Q3: Δ+42 · h=822 2020Q4: Δ+126 · h=948 2021Q1: Δ+39 · h=987 2021Q2: Δ+18 · h=1005 2021Q3: Δ+28 · h=1033 2021Q4: Δ+56 · h=1089 2022Q1: Δ-69 · h=1020 2022Q2: Δ-79 · h=941 2022Q3: Δ-30 · h=911 2022Q4: Δ+73 · h=984 2023Q1: Δ+55 · h=1039 2023Q2: Δ+11 · h=1050 2023Q3: Δ-7 · h=1043 2023Q4: Δ+92 · h=1135 2024Q1: Δ-3 · h=1132 2024Q2: Δ-35 · h=1097 2024Q3: Δ+7 · h=1104 2024Q4: Δ+7 · h=1111 2025Q1: Δ+15 · h=1126 2025Q2: Δ+98 · h=1224 2025Q3: Δ+59 · h=1283 2025Q4: Δ+86 · h=1369 2026Q1: Δ-75 · h=1294 2018Q1: holders=626 2018Q2: holders=638 2018Q3: holders=672 2018Q4: holders=650 2019Q1: holders=663 2019Q2: holders=694 2019Q3: holders=701 2019Q4: holders=738 2020Q1: holders=732 2020Q2: holders=780 2020Q3: holders=822 2020Q4: holders=948 2021Q1: holders=987 2021Q2: holders=1005 2021Q3: holders=1033 2021Q4: holders=1089 2022Q1: holders=1020 2022Q2: holders=941 2022Q3: holders=911 2022Q4: holders=984 2023Q1: holders=1039 2023Q2: holders=1050 2023Q3: holders=1043 2023Q4: holders=1135 2024Q1: holders=1132 2024Q2: holders=1097 2024Q3: holders=1104 2024Q4: holders=1111 2025Q1: holders=1126 2025Q2: holders=1224 2025Q3: holders=1283 2025Q4: holders=1369 2026Q1: holders=1294 -126 -63 +0 +63 +126 56310011438 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 20 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 4% -12.8% —
2025Q3 Top 3% -5.7% -17.3%
2025Q2 Top 1% +8.2% -0.5%
2025Q1 Top 16% +22.0% +28.2%
2023Q4 Top 4% -2.2% -10.5%
2023Q2 Top 19% -9.1% +13.9%
2023Q1 Top 1% -0.1% -5.5%
2022Q4 Top 4% -2.8% -4.5%

Options Sentiment

Put holders
14
QoQ: +1
Call holders
11
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
40.6
EPS (TTM)
$13.59
EPS YoY
+25.6%
Revenue (TTM)
$4.4B
Revenue YoY
+13.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.9B 2022-09-30: $0.8B 2022-12-31: $0.8B 2023-03-31: $0.9B 2023-06-30: $0.9B 2023-09-30: $0.9B 2023-12-31: $0.9B 2024-03-31: $1.0B 2024-06-30: $1.0B 2024-09-30: $1.0B 2024-12-31: $1.0B 2025-03-31: $1.0B 2025-06-30: $1.1B 2025-09-30: $1.1B 2025-12-31: $1.1B 2026-03-31: $1.1B 2022-06-30: EPS 1.56 2022-09-30: EPS 2.15 2022-12-31: EPS 2.05 2023-03-31: EPS 2.55 2023-06-30: EPS 2.67 2023-09-30: EPS 2.53 2023-12-31: EPS 2.31 2024-03-31: EPS 2.81 2024-06-30: EPS 2.44 2024-09-30: EPS 2.80 2024-12-31: EPS 2.62 2025-03-31: EPS 2.96 2025-06-30: EPS 3.63 2025-09-30: EPS 3.40 2025-12-31: EPS 3.09 2026-03-31: EPS 3.47 0B 0.6B 1.1B $B 0.00 2.00 3.99 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 49 2023-03-31: PE 58.62023-06-30: PE 532023-09-30: PE 47.62023-12-31: PE 55.22024-03-31: PE 52.72024-06-30: PE 48.82024-09-30: PE 40.62024-12-31: PE 41.72025-03-31: PE 47.92025-06-30: PE 54.22025-09-30: PE 54.72025-12-31: PE 48.12026-03-31: PE 38.9 35 48 62 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)